BASEL, SWITZERLAND: Lonza Group has completed the acquisition of Capsugel SA (Capsugel) from KKR & Co, for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion.
The acquisition of Capsugel, a world leader in advanced oral dosage delivery technologies with a leading position in hard capsules, is expected to be accretive to Lonza’s core earnings per share in the first full year post closing.
BASEL, SWITZERLAND: Lonza Group has completed the acquisition of Capsugel SA (Capsugel) from KKR & Co, for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion.
The acquisition of Capsugel, a world leader in advanced oral dosage delivery technologies with a leading position in hard capsules, is expected to be accretive to Lonza’s core earnings per share in the first full year post closing.
No comments:
Post a Comment